Scibase AB (Sweden) Performance
| SCIB Stock | SEK 0.42 0.03 7.69% |
On a scale of 0 to 100, Scibase AB holds a performance score of 3. The entity has a beta of -0.0427, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Scibase AB are expected to decrease at a much lower rate. During the bear market, Scibase AB is likely to outperform the market. Please check Scibase AB's standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Scibase AB's existing price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Scibase AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Scibase AB unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 41.4 M | |
| Total Cashflows From Investing Activities | -526 K |
Scibase |
Scibase AB Relative Risk vs. Return Landscape
If you would invest 40.00 in Scibase AB on September 23, 2024 and sell it today you would earn a total of 2.00 from holding Scibase AB or generate 5.0% return on investment over 90 days. Scibase AB is generating 0.2269% of daily returns and assumes 5.627% volatility on return distribution over the 90 days horizon. Simply put, 50% of stocks are less volatile than Scibase, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Scibase AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scibase AB's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Scibase AB, and traders can use it to determine the average amount a Scibase AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0403
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SCIB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.63 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Scibase AB is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scibase AB by adding it to a well-diversified portfolio.
Scibase AB Fundamentals Growth
Scibase Stock prices reflect investors' perceptions of the future prospects and financial health of Scibase AB, and Scibase AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Scibase Stock performance.
| Return On Equity | -0.9 | |||
| Return On Asset | -0.43 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (2.59) % | |||
| Current Valuation | 208.42 M | |||
| Shares Outstanding | 68.48 M | |||
| Price To Earning | (2.75) X | |||
| Price To Book | 7.00 X | |||
| Price To Sales | 16.25 X | |||
| Revenue | 11.73 M | |||
| EBITDA | (38.82 M) | |||
| Cash And Equivalents | 65.61 M | |||
| Cash Per Share | 3.49 X | |||
| Total Debt | 356 K | |||
| Book Value Per Share | 0.37 X | |||
| Cash Flow From Operations | (39.5 M) | |||
| Earnings Per Share | (0.66) X | |||
| Total Asset | 85.46 M | |||
| Retained Earnings | (352 M) | |||
| Current Asset | 106 M | |||
| Current Liabilities | 10 M | |||
About Scibase AB Performance
Assessing Scibase AB's fundamental ratios provides investors with valuable insights into Scibase AB's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Scibase AB is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and internationally. The company was founded in 1998 and is headquartered in Stockholm, Sweden. Scibase Holding operates under Diagnostics Research classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.Things to note about Scibase AB performance evaluation
Checking the ongoing alerts about Scibase AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Scibase AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Scibase AB had very high historical volatility over the last 90 days | |
| Scibase AB has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 11.73 M. Net Loss for the year was (41.78 M) with profit before overhead, payroll, taxes, and interest of 11.23 M. | |
| Scibase AB has accumulated about 65.61 M in cash with (39.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 26.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Scibase AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Scibase AB's stock is overvalued or undervalued compared to its peers.
- Examining Scibase AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Scibase AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Scibase AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Scibase AB's stock. These opinions can provide insight into Scibase AB's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.